Patents by Inventor D. Lynn Kirkpatrick

D. Lynn Kirkpatrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds, compositions and methods for inhibiting CNKSR1
    Patent number: 10227356
    Abstract: Compounds that inhibit CNKSR1, pharmaceutical compositions including compounds that inhibit CNKSR1 and methods of treating disease or disorders that respond to CNKSR1 inhibition are described herein. Additionally, methods of identifying inhibitors of CNKSR1 are described.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: March 12, 2019
    Assignee: PHUSIS THERAPEUTICS, INC.
    Inventors: D. Lynn Kirkpatrick, Martin Indarte
  • COMPOUNDS, COMPOSITIONS AND METHODS FOR INHIBITING CNKSR1
    Publication number: 20160304533
    Abstract: Compounds that inhibit CNKSR1, pharmaceutical compositions including compounds that inhibit CNKSR1 and methods of treating disease or disorders that respond to CNKSR1 inhibition are described herein. Additionally, methods of identifying inhibitors of CNKSR1 are described.
    Type: Application
    Filed: April 20, 2016
    Publication date: October 20, 2016
    Applicant: Phusis Therapeutics, Inc.
    Inventors: D. Lynn KIRKPATRICK, Martin INDARTE
  • Methods and compositions for inhibiting CNKSR1
    Patent number: 9340532
    Abstract: Embodiments include compositions and methods of inhibiting CNKSR1 and methods of identifying inhibitors of CNKSR1.
    Type: Grant
    Filed: December 16, 2013
    Date of Patent: May 17, 2016
    Assignee: Phusis Therapeutics, Inc.
    Inventors: D. Lynn Kirkpatrick, Martin Indarte, Nathan T. Ihle
  • METHODS AND COMPOSITIONS FOR INHIBITING CNKSR1
    Publication number: 20150307482
    Abstract: Embodiments include compositions and methods of inhibiting CNKSR1 and methods of identifying inhibitors of CNKSR1.
    Type: Application
    Filed: December 16, 2013
    Publication date: October 29, 2015
    Applicant: PHUSIS THERAPEUTICS, INC.
    Inventors: D. LYNN KIRKPATRICK, MARTIN INDARTE, NATHAN T. IHLE
  • Single walled carbon nanotube/sirna complexes and methods related thereto
    Patent number: 8772258
    Abstract: The present invention includes single-walled carbon nanotube compositions for the delivery of bioactive agents and methods of making such single-walled carbon nanotube compositions.
    Type: Grant
    Filed: July 1, 2011
    Date of Patent: July 8, 2014
    Assignee: Ensysce Biosciences, Inc.
    Inventors: D. Lynn Kirkpatrick, Michelle K. Weiss
  • PHARMACEUTICAL COMPOSITIONS AND FORMULATIONS INCLUDING INHIBITORS OF THE PLECKSTRIN HOMOLOGY DOMAIN AND METHODS FOR USING SAME
    Publication number: 20120189670
    Abstract: Pleckstrin homology domain binding compounds, pharmaceutical compositions including such compounds, and methods for their use are described herein.
    Type: Application
    Filed: September 14, 2010
    Publication date: July 26, 2012
    Inventors: D. Lynn Kirkpatrick, Jennifer L. H. Johnson
  • SINGLE-WALLED CARBON NANOTUBE/SIRNA COMPLEXES AND METHODS RELATED THERETO
    Publication number: 20120003278
    Abstract: The present invention includes single-walled carbon nanotube compositions for the delivery of bioactive agents and methods of making such single-walled carbon nanotube compositions.
    Type: Application
    Filed: July 1, 2011
    Publication date: January 5, 2012
    Applicant: ENSYSCE BIOSCIENCES, INC.
    Inventors: D. Lynn Kirkpatrick, Michelle K. Weiss
  • Asymmetric disulfides and methods of using same
    Publication number: 20030176512
    Abstract: The present invention is directed to a composition or formulation which includes an asymmetric disulfide which alone or in combination inhibits or interferes with cellular redox function, as well as a method of using same to restore normal cellular function. More specifically, the composition of the present invention interacts with, interferes with or inhibits abnormal cellular proliferation and restores or prevents inhibition of cellular apoptosis.
    Type: Application
    Filed: February 14, 2003
    Publication date: September 18, 2003
    Inventor: D. Lynn Kirkpatrick
  • Asymmetric disulfides and methods of using same
    Patent number: 6552060
    Abstract: The present invention is directed to a composition or formulation which includes an asymmetric disulfide which alone or in combination inhibits or interferes with cellular redox function, as well as a method of using same to restore normal cellular function. More specifically, the composition of the present invention interacts with, interferes with or inhibits abnormal cellular proliferation and restores or prevents inhibition of cellular apoptosis.
    Type: Grant
    Filed: August 11, 1998
    Date of Patent: April 22, 2003
    Assignee: Prolx Pharmaceuticals, Inc.
    Inventor: D. Lynn Kirkpatrick
  • Inhibitors of redox signaling and methods of using same
    Patent number: 6372772
    Abstract: The present invention is directed to a composition or formulation which inhibits or interferes with cellular redox function, and method of using same to restore normal cellular function. More specifically, the composition of the present invention interferes with or inhibits abnormal cellular proliferation and//restores or cellular apoptosis.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: April 16, 2002
    Assignee: Prolx Pharmaceuticals Corporation
    Inventors: D. Lynn Kirkpatrick, Garth Powis